Triptolide (CAS 38748-32-2): A Potent Anti-Tumor Compound with Broad Gene Transcription Inhibition Properties

Explore the powerful anti-cancer potential of Triptolide, a compound showing remarkable efficacy in preclinical studies.

Get a Quote & Sample

Key Advantages Offered

Broad-Spectrum Anti-Cancer Efficacy

Triptolide exhibits significant anti-tumor properties, making it a valuable agent for exploring cancer treatment avenues.

Unique Gene Transcription Inhibition

The compound's ability to inhibit broad gene transcription provides a distinct mechanism for drug development, potentially overcoming resistance to conventional therapies.

Targeted Molecular Action

By promoting Rpb1 phosphorylation and degradation, Triptolide offers a targeted approach at the molecular level, enhancing its therapeutic precision.

Key Applications

Oncology Research

Triptolide serves as a vital tool for researchers investigating new cancer therapeutics research and understanding cellular pathways.

Drug Discovery & Development

Its unique properties make it a candidate for drug discovery programs focused on novel anti-cancer agents.

Mechanism of Action Studies

Scientists can utilize Triptolide to study the intricate mechanisms of gene transcription inhibition and DNA damage response.

Pharmaceutical Intermediate Use

As a key pharmaceutical intermediate, it can be crucial in the synthesis of more complex therapeutic molecules.